Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of “thyroid-checked” controls-Reference-Cited by-同舟云学术

Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of “thyroid-checked” controls

Published:2017-03 Issue:3 Volume:60 Page:178-184
ISSN:1769-7212
Container-title:European Journal of Medical Genetics
language:en
Short-container-title:European Journal of Medical Genetics

Author:

Kern Benjamin,Coppin Lucie,Romanet Pauline,Crépin Michel,Szuster Isabelle,Renaud Florence,Leteurtre Emmanuelle,Frénois Frédéric^ORCID,Wemeau Jean-Louis,Carnaille Bruno,Cardot-Bauters Catherine,Do Cao Christine,Pigny Pascal

Publisher

Elsevier BV

Subject

Genetics (clinical),Genetics,General Medicine

Reference18 articles.

1. Endometrial gene expression analysis at the time of embryo implantation in women with unexplained infertility;Altmäe;Mol. Hum. Reprod.,2010

2. Clinicopathological features and prognosis of fPTC-a large scale, matched, case-control study;Cao;Clin. Endocrinol.,2016

3. Germline HABP2 mutation causing familial non medullary thyroid cancer;Gara;N. Engl. J. Med.,2015

4. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells;Jeon;Int. J. Oncol.,2006

5. Analysis of protein-coding genetic variation in 60,706 humans;Lek;Nature,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of P21 (CDKN1A) Activated Kinase 4 as a Susceptibility Gene for Familial Non-Medullary Thyroid Carcinoma;Thyroid®;2024-05-01

2. Chromosomal localization of mutated genes in non-syndromic familial thyroid cancer;Frontiers in Oncology;2024-03-20

3. Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys;Frontiers in Endocrinology;2022-02-28

4. Nonsyndromic Familial Thyroid Cancer;Endocrine Pathology;2022

5. Familial non-medullary thyroid carcinoma: clinico-pathological features, current knowledge and novelty regarding genetic risk factors;Minerva Endocrinology;2021-03